-
Programmed Cell Death Ligand 1 (PD-L1) and major Histocompatibility Complex Class I (MHC Class I) Expression Patterns and Their Pathologic Associations in triple-Negative Breast Cancer
06 Feb 2025 08:13 GMT
… L1) expression in triple negative breast cancer (TNBC). Breast Cancer. 2018;25(1):34 … immunotherapy in Triple-Negative Breast Cancer (TNBC). Clinical Breast Cancer. 2024;24:263–270 … poor prognosis in patients with advanced breast cancer. J Pathol Transl Med. …
-
Anti-HER2 Bispecific ADC JSKN003 Received Approval to Initiate a Phase III Clinical Study for the Treatment of HER2-positive Breast Cancer
06 Feb 2025 07:59 GMT
… the treatment of HER2-positive advanced breast cancer. This marks the third Phase … HER2-positive, unresectable locally advanced or metastatic breast cancer who have previously received …
-
AI can aid in early, precise detection of breast cancer, show results of 1st randomised trial
06 Feb 2025 05:43 GMT
… they first formed.
The advanced screening method also led … the extensive use of advanced AI tools.
A senior … hereditary risk of breast cancer or a history of breast cancer.
The project … since stage majorly influenced breast cancer treatment and prognosis, they …
-
Two experts agree Verzenio increases chances of cure for women with high risk of early breast cancer
06 Feb 2025 07:50 GMT
… therapy in early-stage breast cancer.
Against this backdrop, … age group have as advanced life necessities lifestyles as … and outcomes for early breast cancer have progressively evolved … perception and reality of breast cancer prognosis.
“Adjuvant treatment …
-
World News in Brief: US executive orders continue, killings in Sudan, breast cancer alert in Africa, human rights in Tunisia
06 Feb 2025 00:48 GMT
… has “saved countless lives and advanced global security”.
“As I have … significant gaps and disparities in breast cancer control.
Key findings included a … sub-Saharan Africa have regular breast cancer screening programmes. Lab screening facilities …
-
FDA Considers BLA for Pertuzumab Biosimilar HLX11 in Breast Cancer
05 Feb 2025 23:12 GMT
… select patients with HER2-positive breast cancer.
HLX11 is an investigational … patients with HER2-positive breast cancer that is locally advanced, inflammatory, or early … -negative, early-stage or locally advanced breast cancer further support its use.
In …
-
Significant Increase in Breast Cancer Cases Among Young Americans Following COVID-19 Vaccine Rollout
05 Feb 2025 17:33 GMT
… vaccines.
By yourNEWS Media Newsroom
Breast cancer cases in Americans under 45 … scientifically proven.
Many of these breast cancer victims have no family history … individuals diagnosed with advanced stages of lymphoma or breast cancer without early warning …
-
Dr Winer on Considerations for Inavolisib Plus Palbociclib and Fulvestrant in PIK3CA-Mutated HR+/HER2– Breast Cancer
05 Feb 2025 17:13 GMT
… ) with fulvestrant (Faslodex) in the advanced setting for select patients with … receptor (HR)–positive, HER2-negative breast cancer, following the FDA approval of … at the 2024 San Antonio Breast Cancer Symposium (SABCS), discussion centered on …
-
Benign Breast Disease and Early Breast Cancer Market Expected to Experience Major Growth by 2034, States DelveInsight
05 Feb 2025 16:45 GMT
… for treating patients with advanced or metastatic breast cancer. This global, multi- … increase the risk of breast cancer.
Early Breast Cancer refers to cancer that … ablation in breast cancer
Benign Breast Disease and Early Breast Cancer Market …
-
Novartis’ Kisqali granted MHRA approval to treat early breast cancer patients
05 Feb 2025 12:30 GMT
… UK for certain cases of advanced breast cancer.
The MHRA’s latest decision … risk of recurrence in early breast cancer, addressing a significant unmet need … NHS.
Stephen Johnston, professor of breast cancer medicine, consultant medical oncologist, and …
About
© 1995-2025